ApprovalTrail

Approval · Notice of Compliance 3304 · 1997

LICLOFEN: Notice of Compliance 3304

Issued October 17, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3304
Date
October 17, 1997
Company
Technilab Pharma Inc.Mirabel, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Muscle relaxant, antispastic agent

Products in this notice

BrandDINStatus today
LICLOFEN02236508Cancelled Post Market
LICLOFEN02236507Cancelled Post Market

Medicinal ingredients